This presentation is the property of its rightful owner.
Sponsored Links
1 / 67

第九章 . 传染与免疫 PowerPoint PPT Presentation


  • 78 Views
  • Uploaded on
  • Presentation posted in: General

第九章 . 传染与免疫. Chapter 9 Infection and Immunity. 病原微生物感染. 机体对抗. (免疫学). 传统的免疫概念:. 机体抵抗病原微生物的能力,即 抗传染免疫 。. 免疫 (immunity) :. 生物体能够辩认自我与非自我,对非我做 出反应以保持自身稳定的功能。. 意义 :1. 传染病防治 2. 发展最快影响最大的学科之一 3. 对生物学重要理论研究的作用 ( 准确、灵敏 pg 检测 ) 4. 对疾病诊断和治疗的作用. 第一节 传染. 一、 传染与传染病

Download Presentation

第九章 . 传染与免疫

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


4250115

.

Chapter 9 Infection and Immunity


4250115

(immunity)

:1.

2.

3.(pg)

4.


4250115

(disease)

pathogen pathogenic microorganisms


4250115


4250115

1(invasiveness)


4250115

1

  • Vibrio

  • Shigella ddysenteriae

  • Streptococcus haemolyticus


4250115

2

AM

E.coli K

3

a


4250115

b

c

d

e


4250115

2(toxin)

:

1exotoxin

,


4250115

0.3~0.4%

toxoidantitoxin

0.3-0.4%


4250115

2endotoxin

(LPS)


4250115

Ca2+

LALB

B

()

)

2~3 1hr


4250115

*1mg0.22000100%1mg1001mg1000


4250115

2

3


4250115

immunity


4250115

:

1.2.3.


4250115

(apparent infection)

1 2

3 4

3

(inapparent infection)

(carrier state)

Mary Mallon

71500


4250115

nonspecific immunity


4250115

:

1.2.3.4.

()

20-80um

1.2.3.4.


4250115

C1C2C3C9BPCR

FcC1

C1sC4C2C3(C3 convertase)C3C5

C5b9membrane attack compoundMAC

SSC5b7SC5b8SC5b9


4250115

1

C5~C9

2

3

C3aC5aC5

4

5

C3aC5aor


4250115

interferon IFN

1957 Issacs Lindenmann

1

1

IIFN IFN

II IFN T

2

60C 1h pH 2~11

1NK

2

3B


4250115


4250115

specific immunity

1

2

3

4


Immune response

:

:

immune response


4250115

1

12

2T

1--

2

3


4250115

*

T

B

1NK

2K

NKTTNK


4250115


Antigen ag

antigen,Ag

:T

1 2

:


Antibody ab

1

2

3

4

5antiantibody

immunoglobulin,Ig

antibody,Ab


4250115

Ig

.

.

30

.

.CHO

.


4250115

Ig


4250115

IgG


4250115

Igconformation


4250115


4250115

1.(1012)

2.

3.

4.


4250115

monoclonal antibody,McAbB

  • lymphocyte hybridomahybridomaBMcAb


4250115

1

HGPRT

B

2

3:PEG

4: HAT

5:

6


4250115

1

2

3

4

5


4250115

agglutination

precipitation


4250115

1

1

2

2

1

2

3

4

5


Complement fixation test cft

1

2

3

complement fixation test ,CFT


Immunolabelling technique

(immunoenzymatic technique)

1 (enzyme linked immunosorbant assay, ELISA)

1)(sandwich ELISA)

2)(indirect ELISA)

3)(dot-ELISA)

2(enzyme-labellingimmunolocalization)

1)(immuno-histochemistry)

2)(immunoblot,westernblot)

immunolabelling technique


4250115

(immunofluorescens technique)

(fluorescent antibody technique,FAT)

(radioimmuno-assay, RIA)

(immuno-electron microscopy, IEM)

(luminescent immuno-assay,LIA)


4250115

biologics,biologic products

  • 1

    artificial active immunization

    2

    (artificial passive immunization)


4250115


4250115

1vaccine

2toxoid

3autovaccine

1(subunit vaccine)

2(chemical vaccine)

3(polypeptide vaccine)

4

5DNA( DNA vaccine)

6 (anti-idiotype antibody vaccine)


4250115

1(antitoxin)

2(antiviral serum)

3(aantibacterial serum)

4

5(immune RNA,iRNA)

immunoregulative preparation


4250115

1T

2-2TTSNK

3T

4T

5TB

6

7


  • Login